Ethic Inc. Eli Lilly & CO Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ethic Inc. holds 69,767 shares of LLY stock, worth $52.1 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

69,767

Previous 74,103 5.85%

Holding current value

$52.1 Million

Previous $67.1 Million 7.87%

% of portfolio

1.56%

Previous 1.59%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $3.35 Million - $4.16 Million	-4,336 Reduced 5.85%	69,767 $61.8 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $3.14 Million - $3.94 Million	4,336 Added 6.21%	74,103 $67.1 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $4.3 Million - $5.75 Million	7,255 Added 11.61%	69,767 $54.3 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.02 Million - $1.2 Million	1,940 Added 3.2%	62,512 $36.4 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.2 Million - $3.03 Million	5,059 Added 9.11%	60,572 $32.5 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $323,031 - $431,930	921 Added 1.69%	55,513 $26 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $1.71 Million - $2.01 Million	5,514 Added 11.24%	54,592 $18.7 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.94 Million - $2.26 Million	6,023 Added 13.99%	49,078 $18 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.74 Million - $1.98 Million	5,866 Added 15.77%	43,055 $13.9 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $5.93 Million - $6.96 Million	21,275 Added 133.69%	37,189 $12.1 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $2.28 Million - $2.84 Million	-9,729 Reduced 37.94%	15,914 $4.56 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $3.04 Million - $3.78 Million	13,533 Added 111.75%	25,643 $7.08 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $690,505 - $849,764	3,116 Added 34.65%	12,110 $2.8 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $764,809 - $989,275	-4,236 Reduced 32.02%	8,994 $2.06 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $283,944 - $367,580	1,728 Added 15.02%	13,230 $2.47 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $314,408 - $416,038	2,410 Added 26.51%	11,502 $1.94 Million
Q3 2020 Oct 27, 2020	BUY	$146.22 - $169.13 $183,652 - $212,427	1,256 Added 16.03%	9,092 $1.35 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $168,342 - $202,598	1,234 Added 18.69%	7,836 $1.29 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $93,335 - $115,522	784 Added 13.48%	6,602 $916,000
Q4 2019 May 22, 2020	BUY	$106.92 - $132.43 $102,857 - $127,397	962 Added 19.81%	5,818 $765,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $519,203 - $643,080	4,856 New	4,856 $638,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account